donor healthcare-industry insurance anthem elevance single-payer-opponent follow-the-money california medicare-advantage lobbying pbm
related: _Gavin Newsom Master Profile · Single-Payer Broken Promise · Prescription Drug Pricing - PBM Veto Cycle · Blue Shield of California · UnitedHealth Group - Optum · PBM Industry Bloc - OptumRx, CVS Caremark, Express Scripts
Who They Are
Anthem, rebranded as Elevance Health in 2022, is one of the largest for-profit health insurance companies in the United States. Revenue: $175.2 billion (2024), up to $197.6 billion (2025). Profit: $5.7 billion (2025). Operates Blue Cross Blue Shield plans in 14 states, including California (Anthem Blue Cross). Serves approximately 46 million medical members. Traded as ELV on NYSE.
CEO Gail Boudreaux earned $20.5 million in total compensation in 2024 ($1.6M salary, $1.1M bonus, $4.2M stock options, $12.6M stock awards). The five highest-paid executives collectively earned over $60 million.
Elevance operates its own PBM subsidiary, IngenioRx (rebranded from Anthem’s pharmacy services), managing drug benefits for its insured population. This creates the same vertical integration conflict as Optum: the insurer controls which drugs are covered, at what price, through its own pharmacy benefit manager — extracting profit at every stage of the healthcare transaction.
What They Want
- Preservation of private insurance market — no single-payer legislation at state or federal level
- Minimal PBM transparency regulation (Elevance has its own PBM, IngenioRx)
- Favorable Medicare Advantage contracts and rate increases (projecting 7-9% MA enrollment growth for 2025)
- Favorable Medi-Cal managed care contracts in California
- No private equity oversight in healthcare acquisitions
- Continued employer-sponsored insurance model as default American healthcare
- Weakened administrative state regulation of insurance practices
Who They Fund
Federal Political Action Committee (Elevance Health PAC):
- Raised $3.17 million in the 2023-2024 election cycle
- Contributed $1.15 million to federal candidates in 2023-2024
- Bipartisan distribution: funds members of both parties on key health committees (Energy & Commerce, Finance, Ways & Means, HELP)
California State-Level:
- Gavin Newsom — $130,000 to Newsom’s campaigns since 2011
- California Democratic Party — $513,000 since 2007
Federal Lobbying:
- $10.6 million in federal lobbying spending (2024)
- $1.38 million disclosed in Q2 2025 alone
- Part of the healthcare insurance industry’s collective $16M+ quarterly lobbying spend (alongside UnitedHealth, Cigna, BCBS Association, Humana)
- Lobbies on: Medicare Advantage rate methodology, Medicaid managed care requirements, PBM regulation, ACA marketplace rules, prior authorization reform
Industry Association:
- Member of AHIP (America’s Health Insurance Plans) — the insurance industry’s primary lobbying organization, which spent $6.2 million on lobbying in the 2024 cycle
What They’ve Gotten
California:
- Single-payer (AB 1400 / CalCare) died without Newsom’s support in January 2022. Anthem’s California business survives.
- PBM oversight vetoed in September 2024 — protects IngenioRx from transparency requirements.
- “Universal coverage” framing (Medi-Cal expansion) brought new customers into managed care rather than eliminating the insurance industry. Anthem participates in Medi-Cal managed care — more covered lives means more premium revenue.
Federal:
- Medicare Advantage continues to grow as the primary vehicle for privatizing Medicare. Elevance projects 7-9% MA enrollment growth for 2025. Each new MA enrollee shifts a Medicare beneficiary from the public program into a for-profit insurance plan.
- PBM reform legislation repeatedly stalled in Congress despite bipartisan support — protecting Elevance’s IngenioRx subsidiary from transparency mandates.
- ACA marketplace continues as employer-sponsored + individual market model rather than single-payer — Elevance sells plans on every exchange where it operates.
Money
The insurance industry’s combined lobbying ($16M+/quarter) and PAC spending ($3M+ per cycle per company) buys a very specific outcome: the continued existence of private health insurance as the American default. Every policy “win” — Medi-Cal expansion, ACA marketplace growth, Medicare Advantage enrollment increases — routes more people through private insurers rather than public programs. The industry doesn’t need to kill universal coverage directly. It just needs to ensure that “universal coverage” means universal enrollment in private insurance.
The Insurance Bloc Pattern
Anthem’s contribution profile mirrors the broader insurance industry pattern across the vault:
| Company | Direct to Newsom | To CA Dem Party | Federal PAC (2024 cycle) | Federal Lobbying (2024) |
|---|---|---|---|---|
| Anthem/Elevance | $130K | $513K | $3.17M raised | $10.6M |
| Blue Shield of California | $99K | $2.7M | — (state only) | — |
| UnitedHealth Group - Optum | $131K | — | $4.5M+ raised | $12.4M |
| Combined | $360K+ | $3.2M+ | $7.7M+ | $23M+ |
The combined picture: three companies spent $360K+ on one governor, $3.2M+ on one state party, $7.7M+ through federal PACs, and $23M+ on federal lobbying — and the structural result is that single-payer remains politically impossible in both California and Washington. The insurance bloc doesn’t coordinate formally; it doesn’t need to. Each company independently funds the same politicians and lobbies against the same reforms because their class interests are identical.
Class Analysis
Elevance Health is a pure extraction machine: it sits between patients and doctors, collects premiums, denies claims, and pays executives $20M+/year. The rebranding from “Anthem” to “Elevance Health” in 2022 was itself a class signal — removing the word “insurance” from the corporate identity while the business model remained entirely insurance-based. The company doesn’t provide healthcare. It provides access to healthcare, contingent on payment, subject to denial, and profitable regardless of patient outcomes.
The Medicare Advantage expansion is the long game. Each year, more Medicare beneficiaries are enrolled in MA plans — Elevance projects 7-9% growth in 2025 alone. This isn’t market competition; it’s structural privatization. The public Medicare program slowly shrinks as private insurers absorb its beneficiaries, collect government payments, and add profit extraction on top. Elevance’s lobbying ensures this trend continues: favorable MA rate methodology, no public option competition, no single-payer alternative.
Sources
- OpenSecrets: Elevance Health PAC Profile, 2023-2024 cycle (Tier 1)
- OpenSecrets: Elevance Health Lobbying Profile (Tier 1)
- FEC: Elevance Health PAC filings (Tier 1)
- The Lever: Newsom’s Big Choice — Single Payer or His Insurance Donors (Tier 2)
- Fierce Healthcare: Elevance Health Q4 2024 earnings, $175.2B revenue (Tier 2)
- Becker’s Payer Issues: Elevance Health 5 highest-paid executives 2024 (Tier 2)
- National Institute on Money in Politics: FollowTheMoney.org — Anthem/Elevance state contributions (Tier 1)
research-status:: ready — Promoted Session 39. — Expanded from draft with federal PAC data ($3.17M raised, $1.15M to candidates), federal lobbying ($10.6M/year), CEO compensation ($20.5M), Medicare Advantage growth projections, insurance bloc comparison table, class analysis. 7 sources, Tier 1-2. All headers. Needs FPPC primary verification for California figures and revolving door documentation before ready promotion. content-readiness:: ready